Viewing Study NCT00244634


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-02-24 @ 5:45 AM
Study NCT ID: NCT00244634
Status: COMPLETED
Last Update Posted: 2007-12-19
First Post: 2005-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module